Abstract
Nanoparticle-based delivery systems are versatile tools to improve drug delivery because size, surface charge and surface hydrophobicity can be varied to meet specific physiological requirements. While small size, hydrophobicity, and positive surface charge, in general, improve passage through the plasma membrane and enhance intracellular delivery, these particle parameters may not be optimal if a mucus layer covers the target cells. Many target cells for drug delivery in the gastrointestinal tract but also in the respiratory tract are covered by mucus. The review describes the different compositions of mucus-covered epithelia of the oro-gastrointestinal and the respiratory tract and strategies to reach target cells beyond the mucus layer by the design of appropriate nanocarriers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AP-1:
-
Activator protein 1
- CREB:
-
cAMP response element binding protein
- EGFR:
-
Epidermal growth factor receptor
- ERK:
-
Extracellular signal-regulated kinase
- IL:
-
Interleukin
- JNK:
-
Jun N-terminal kinase
- LPS:
-
Lipopolysaccharide
- MEK:
-
Mitogen-activated protein kinase kinase
- MSK1:
-
Mitogen and stress activated protein kinase
- MUC:
-
Mucin
- MyD88:
-
Myeloid differentiation primary response gene 88
- NIK:
-
NFkB-inducing kinase
- NFkB:
-
Nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells
- p38:
-
p38 mitogen-activated protein kinase
- PTS:
-
proline, serine, and threonine
- ROS:
-
Reactive oxygen species
- SP1:
-
Specificity protein 1
- Src:
-
Rous sarcoma oncogene cellular homolog
- STAT:
-
Signal transducer and activator of transcription
- TAK1:
-
TGF β-activated kinase
References
Albrecht K, Greindl M, Kremser C, Wolf C, Debbagec B, Bernkop-Schürch A (2006) Comparative in vivo mucoadhesion studies ofthiomer formulations using magnetic resonance imaging and fluorescence detection. J Control Release 115:78–84
Ali MS, Pearson JP (2007) Upper airway mucin gene expression: a review. Laryngoscope 117:932–938
Aljayyoussi G, Abdulkarim M, Griffiths P, Gumbleton M (2012) Pharmaceutical nanoparticles and the mucin biopolymer barrier. BioImpacts BI 2:173–174
Anand U, Feridooni T, Agu R (2012) Novel mucoadhesive polymers for nasal delivery. In: Seizer A (ed) Recent advances in novel drug carrier systems. InTech
Aoki Y, Morishita M, Takayama K (2005) Role of the mucous/glycocalyx layers in insulin permeation across the rat ileal membrane. Int J Pharm 297:98–109
Bernkop-Schnürch A, Steininger S (2000) Synthesis and characterization of mucoadhesive thiolated polymers. Int J Pharm 194:239–247
Blegamwar V, Shah V, Surana SJ (2009) Formulation and evaluation of oral mucoadhesive multiparticulate sytsem containing metoprolol tartrate: an in vitro-ex vivo characterization. Curr Drug Deliv 6:113–121
Caramella C, Bonferoni M, Rossi S, Ferrari F (1994) Rheological and tensile tests for the assessment of polymer-mucin interactions. Eur J Pharm Biopharm 40:213–217
Chen J, Zhang C, Liu Q, Shao X, Feng C, Shen Y, Zhang Q, Jiang X (2012) Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations. J Drug Target 20:174–184
Cohen S, Coue G, Beno D, Korenstein R, Engbersen JF (2012) Bioreducible poly(amidoamine)s as carriers for intracellular protein delivery to intestinal cells. Biomaterials 33:614–623
Collins LM, Dawes C (1987) The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res 66:1300–1302
Csaba N, Sanchez A, Alonso MJ (2006) PLGA: poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery. J Control Release 113:164–172
Csaba N, Garcia-Fuentes M, Alonso MJ (2009) Nanoparticles for nasal vaccination. Adv Drug Deliv Rev 61:140–157
Cui F, Qian F, Zhao Z, Yin L, Tang C, Yin C (2009) Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules 10:1253–1258
Davidovich-Pinhas M, Baianco-Peled H (2013) Mucoadhesion: a review of characterization techniques. Expert Opin 7:259–271
Davis CW, Dickey BF (2008) Regulated airway goblet cell mucin secretion. Annu Rev Physiol 70:487–512
Dawson M, Krauland E, Wirtz D, Hanes J (2004) Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnol Prog 20:851–857
Deacon M, McGurk S, Roberts C, Williams P, Tendler S, Davies M, Davies S, Harding S (2000) Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems. Biochem J 348:557–563
Dorofeyev AE, Vasilenko IV, Rassokhina OA, Kondratiuk RB (2013) Mucosal barrier in ulcerative colitis and Crohn’s disease. Gastroenterol Res Pract 2013:431231
Elsayed A, Remawi MA, Qinna N, Farouk A, Badwan A (2009) Formulation and characterization of an oily-based system for oral delivery of insulin. Eur J Pharm Biopharm 73:269–279
Elzagheid A, Emaetig F, Buhmeida A, Laato M, El-Faitori O, Syrjanen K, Collan Y, Pyrhonen S (2013) Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma. Tumour Biol J Int Soc Oncodevelop Biol Med 34:621–628
Ensign LM, Tang BC, Wang YY, Tse TA, Hoen T, Cone R, Hanes J (2012) Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Trans Med 4:138ra179
Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 363:2233–2247
Fallingborg J (1999) Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 46:183–196
Faure M, Moennoz D, Montigon F, Fay LB, Breuille D, Finot PA, Ballevre O, Boza J (2002) Development of a rapid and convenient method to purify mucins and determine their in vivo synthesis rate in rats. Anal Biochem 307:244–251
Figueiredo L, Cadete A, Goncalves LM, Corvo ML, Almeida AJ (2012) Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems. Vaccine 30:6551–6558
Finkbeiner WE, Zlock LT, Morikawa M, Lao AY, Dasari V, Widdicombe JH (2011) Cystic fibrosis and the relationship between mucin and chloride secretion by cultures of human airway gland mucous cells. Am J Physiol Cell Mol Physiol 301:L402–L414
Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI, Neutra MR (1996) Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 184:1045–1059
Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X, Fu S (2006) Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials 27:3482–3490
Grabovaca V, Guggi D, Bernkop-Schnürch A (2005) Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 57:1713–1723
Hagerstrom H, Edsman K (2003) Limitations of the rheological mucoadhesion method: the effect of the choice of conditions and the rheological synergism parameter. Eur J Pharm Biopharm 18:349–357
Han HK, Shin HJ, Ha DH (2012) Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur J Pharm Sci 46:500–507
Hassan E, Gallo J (1990) A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res 7:491–495
Hauber HP, Foley SC, Hamid Q (2006) Mucin overproduction in chronic inflammatory lung disease. Can Respir J J Can Thorac Soc 13:327–335
Hehar SS, Mason JD, Stephen AB, Washington N, Jones NS, Jackson SJ, Bush D (1999) Twenty-four hour ambulatory nasal pH monitoring. Clin Otolaryngol Allied Sci 24:24–25
Hida K, Lai SK, Suk JS, Won SY, Boyle MP, Hanes J (2011) Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients. PLoS ONE 6:e19919
Hunter AC, Elsom J, Wibroe PP, Moghimi SM (2012) Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomed Nanotechnol Biol Med 8(Suppl 1):S5–S20
Issa M, Köping-Höggård M, Artursson P (2005) Chitosan and the mucosal delivery of bio-technology drugs. Drug Discov TodayTechnol 2:1–6
Jayaraman S, Joo NS, Reitz B, Wine JJ, Verkman AS (2001) Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc Natl Acad Sci USA 98:8119–8123
Katayama H, Nishimura T, Ochi S, Tsuruta Y, Yamazaki Y, Shibata K, Yoshitomi H (1999) Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pyroli. Biol Pharm Bull 22:55–60
Kato Y, Onishi H, Machida Y (2003) Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 4:303–309
Kim J, Khan W (2013) Goblet cells and mucins: role in innate defense in enteric infections. Pathogens 2:55–70
Kirch J, Schneider A, Abou B, Hopf A, Schaefer UF, Schneider M, Schall C, Wagner C, Lehr CM (2012) Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus. Proc Natl Acad Sci USA 109:18355–18360
Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109:571–577
Krouse ME (2001) Is cystic fibrosis lung disease caused by abnormal ion composition or abnormal volume? J Gen Physiol 118:219–222
Laboisse C, Jarry A, Branka JE, Merlin D, Bou-Hanna C, Vallette G (1996) Recent aspects of the regulation of intestinal mucus secretion. Proc Nutr Soc 55:259–264
Laffleur F, Hintzen F, Shahnaz G, Rahmat D, Leithner K, Bernkop-Schnurch A (2013) Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus. Nanomedicine [Epub ahead of print]
Lagerlof F, Dawes C (1984) The volume of saliva in the mouth before and after swallowing. J Dent Res 63:618–621
Lai SK, O’Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, Hanes J (2007) Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA 104:1482–1487
Lai SK, Wang YY, Hanes J (2009a) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61:158–171
Lai SK, Wang YY, Wirtz D, Hanes J (2009b) Micro- and macrorheology of mucus. Adv Drug Deliv Rev 61:86–100
Lai SK, Suk JS, Pace A, Wang YY, Yang M, Mert O, Chen J, Kim J, Hanes J (2011) Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials 32:6285–6290
Lee DW, Shirley SA, Lockey RF, Mohapatra SS (2006) Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res 7:112
Lehr C, Bouwstra J, Tukker J, Junginger H (1990) Intestinal transit of bioadhesive microspheres in an in situ loop in the rat-a comparative study with copolymers and blends based on poly (acrylic acid). J Control Release 13:51–62
Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, Basbaum C (1998) Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci USA 95:5718–5723
Li X, Chen D, Le C, Zhu C, Gan Y, Hovgaard L, Yang M (2011) Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake. Int J Nanomed 6:3151–3162
Liu Q, Shen Y, Chen J, Gao X, Feng C, Wang L, Zhang Q, Jiang X (2012) Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles. Pharm Res 29:546–558
Makhlof A, Werle M, Tozuka Y, Takeuchi H (2011) A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J Control Release 149:81–88
Markesich DC, Anand BS, Lew GM, Graham DY (1995) Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel. Gut 36:327–329
Mazzaferro S, Bouchemal K, Skanji R, Gueutin C, Chacun H, Ponchel G (2012) Intestinal permeation enhancement of docetaxel encapsulated into methyl-beta-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan. J Control Release 162:568–574
McGill SL, Smyth HD (2010) Disruption of the mucus barrier by topically applied exogenous particles. Mol Pharm 7:2280–2288
McGuckin MA, Hasnain SZ (2014) There is a ‘uc’ in mucus, but is there mucus in UC? Gut 63:216–217
Merkus FW, Verhoef JC, Schipper NG, Marttin E (1998) Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Deliv Rev 29:13–38
Moghaddam FA, Atyabi F, Dinarvand R (2009) Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles. Nanomed Nanotechnol Biol Med 5:208–215
Mortazavi S, Smart J (1995) An investigation of some factors influencing the in vitro assessment of mucoadhesion. Int J Pharm 116:223–230
Müller C, Leithner K, Hauptstein S, Hintzen F, Salvenmoser W, Bernkop-Schnürch A (2013) Preparation and characterization of mucus-penetrating papain/poly(acrylic acid) nanoparticles for oral drug delivery applications. J Nanopart Res 15(1):1–13
Murty VL, Sarosiek J, Slomiany A, Slomiany BL (1984) Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein. Biochem Biophys Res Commun 121:521–529
Nielsen L, Schubert L, Hansen J (1998) Bioadhesive drug delivery systems. I. Characterization of mucoadhesive properties of systems based on glyceryl monooleate and glycerylmonolinoleate. Eur J Pharm Biopharm 6:231–239
Norris D, Sinko P (1997) Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polym Sci 63:1481–1492
Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA (2001) Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J 81:1930–1937
Ordonez CL, Khashayar R, Wong HH, Ferrando R, Wu R, Hyde DM, Hotchkiss JA, Zhang Y, Novikov A, Dolganov G, Fahy JV (2001) Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 163:517–523
Oyarzun-Ampuero FA, Brea J, Loza MI, Torres D, Alonso MJ (2009) Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int J Pharm 381:122–129
Paliwal R, Paliwal SR, Agrawal GP, Vyas SP (2012) Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Int J Pharm 422:179–184
Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, Hao JS, Cui FD (2002) Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–147
Patel D, Smith J, Smith A, Grist N, Barnett P, Smart J (2000) An atomic force microscopy investigation of bioadhesive polymer adsorption onto human buccal cells. Int J Pharm 200:271–277
Patlolla A, Patlolla B, Tchounwou P (2010) Evaluation of cell viability, DNA damage, and cell death in normal human dermal fibroblast cells induced by functionalized multiwalled carbon nanotube. Mol Cell Biochem 338:225–232
Pires A, Fortuna A, Alves G, Falcao A (2009) Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 12:288–311
Qiang F, Shin HJ, Lee BJ, Han HK (2012) Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm 430:161–166
Rahmat D, Muller C, Barthelmes J, Shahnaz G, Martien R, Bernkop-Schnurch A (2012) Thiolated hydroxyethyl cellulose: Design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles. Eur J Pharm Biopharm 83:149–155
Randell SH, Boucher RC (2006) Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol 35:20–28
Rao K, Buri P (1989) A novel in situ method to test polymers and coated microparticles for bioadhesion. Int J Pharm 52:265–270
Roblegg E, Fröhlich E, Meindl C, Teubl B, Zaversky M, Zimmer A (2012) Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology 6:399–413
Rodrigues S, Dionísio M, Remuñán López C, Grenha A (2012) Biocompatibility of Chitosan carriers with application in drug delivery. J Funct Biomater 3:615–641
Rogers DF (2002) Pharmacological regulation of the neuronal control of airway mucus secretion. Curr Opin Pharmacol 2:249–255
Rogers DF (2007) Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care, 52:1134–1146 (discussion 1146–1139)
Rose MC, Voynow JA (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86:245–278
Rossi S, Ferrari F, Bonferoni MC, Caramella C (2001) Characterization of chitosan hydrochloride–mucin rheological interaction: influence of polymer concentration and polymer: mucin weight ratio. Eur J Pharm Sci 12:479–485
Roy S, Pal K, Anis A, Pramanik K, Prabhakar B (2009) Polymers in mucoadhesive drug delivery system: a brief note. Des Monomers Polym 12:483–495
Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA (2011) Development and in vitro evaluation of thiolated chitosan–Poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system. Int J Biol Macromol 48:403–407
Sakagami M, Sakon K, Kinoshita W, Makino Y (2001) Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J Control Release 77:117–129
Sakloetsakun D, Perera G, Hombach J, Millotti G, Bernkop-Schnurch A (2010) The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate. AAPS PharmSciTech 11:1185–1192
Sakuma S, Sudo R, Suzuki N, Kikuchi H, Akashi M, Hayashi M (1999) Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int J Pharm 177:161–172
Salama HA, Mahmoud AA, Kamel AO, ABDEL HADY M, AWAD GA (2012) Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–154
Salathe M (2007) Regulation of mammalian ciliary beating. Annu Rev Physiol 69:401–422
Sanders NN, de Smedt SC, van Rompaey E, Simoens P, de Baets F, Demeester J (2000) Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am J Respir Crit Care Med 162:1905–1911
Saremi S, Atyabi F, Akhlaghi SP, Ostad SN, Dinarvand R (2011) Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Int J Nanomed 6:119–128
Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R (2007a) Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8:3054–3060
Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D (2007b) Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 24:2198–2206
Sarparanta MP, Bimbo LM, Makila EM, Salonen JJ, Laaksonen PH, Helariutta AM, Linder MB, Hirvonen JT, Laaksonen TJ, Santos HA, Airaksinen AJ (2012) The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems. Biomaterials 33:3353–3362
Schultz M, Callow M, Callow J (2000) A turbulent channel flow apparatus for the determination of the adhesion strength of microfouling organisms. Biofouling 15:243–251
Shahnaz G, Vetter A, Barthelmes J, Rahmat D, Laffleur F, Iqbal J, Perera G, Schlocker W, Dunnhaput S, Augustijns P, Bernkop-Schnurch A (2012) Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm 428:164–170
Shimura S, Andoh Y, Haraguchi M, Shirato K (1996) Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 9:1395–1401
Shirazi T, Longman RJ, Corfield AP, Probert CS (2000) Mucins and inflammatory bowel disease. Postgrad Med J 76:473–478
Simon M, Wittmar M, Kissel T, Linn T (2005) Insulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(L-lactide): bioavailability and nasal tolerability in rats. Pharm Res 22:1879–1886
Singh A, Singh A, Satheesh Madhav N (2012) Nasal cavity: a promising transmucosal platform for drug delivery and research approaches from nasal to brain targetting. J Drug Delivery Thera 2:22–33
Slutter B, Bal SM, Que I, Kaijzel E, Lowik C, Bouwstra J, Jiskoot W (2010) Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles? Mol Pharm 7:2207–2215
Smart JD (2005) The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 57:1556–1568
Specian RD, Oliver MG (1991) Functional biology of intestinal goblet cells. Am J Physiol 260:C183–C193
Suwannateep N, Banlunara W, Wanichwecharungruang SP, Chiablaem K, Lirdprapamongkol K, Svasti J (2011) Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. J Control Release 151:176–182
Tamburic S, Craig DQM (1997) A comparison of different in vitro methods for measuring mucoadhesive performance. Eur J Pharm Biopharm 44:159–167
Tang BC, Dawson M, Lai SK, Wang YY, Suk JS, Yang M, Zeitlin P, Boyle MP, Fu J, Hanes J (2009) Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proc Natl Acad Sci USA 106:19268–19273
Teubl BJ, Meindl C, Eitzlmayr A, Zimmer A, Frohlich E, Roblegg E (2012) In vitro permeability of neutral polystyrene particles via buccal mucosa. Small 9:457–467
Teubl BJ, Absenger M, Frohlich E, Leitinger G, Zimmer A, Roblegg E (2013) The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model. Eur J Pharm Biopharm 84:386–393
Thirawong N, Thongborisute J, Takeuchi H, Sriamornsak P (2008) Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J Control Release 125:236–245
Thorley AJ, Tetley TD (2007) Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chronic Obstructive Pulm Dis 2:409–428
Umamaheshwari RB, Ramteke S, Jain NK (2004) Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model. AAPS PharmSciTech 5:e32
Wang YY, Lai SK, Suk JS, Pace A, Cone R, Hanes J (2008) Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier. Angew Chem 47:9726–9729
Wang X, Zheng C, Wu Z, Teng D, Zhang X, Wang Z, Li C (2009) Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res Part B Appl Biomater 88:150–161
Wang YY, Lai SK, So C, Schneider C, Cone R, Hanes J (2011) Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure. PLoS ONE 6:e21547
Woertz C, Preis M, Breitkreutz J, Kleinebudde P (2013) Assessment of test methods evaluating mucoadhesive polymers and dosage forms: an overview. Eur J Pharm Biopharm 85:843–853
Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y (2005) Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 102:373–381
Yu T, Wang Y, Yang M, Schneider C, Zhong W, Pulicare S, Choi W, Mert O, Lai SK, Hanes J (2012) Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid). Drug Deliv Trans Res 2:124–128
Yuan H, Chen CY, Chai GH, Du YZ, Hu FQ (2013) Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm 10:1865–1873
Zhang X, Zhang H, Wu Z, Wang Z, Niu H, Li C (2008) Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur J Pharm Biopharm 68:526–534
Zhang X, Wang Y, Zheng C, Li C (2012) Phenylboronic acid-functionalized glycopolymeric nanoparticles for biomacromolecules delivery across nasal respiratory. Eur J Pharm Biopharm 82:76–84
Acknowledgements
Support of the studies by FP6 European integrated project “NanoBiopharmaceutics”, NMP4-CT-2006-026723, the Research and Technology Development in Project Cluster NANO-HEALTH and the Austrian Research Promotion Agency (FFG) project 826136 is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fröhlich, E., Roblegg, E. (2014). Mucus as Physiological Barrier to Intracellular Delivery. In: Prokop, A., Iwasaki, Y., Harada, A. (eds) Intracellular Delivery II. Fundamental Biomedical Technologies, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-8896-0_7
Download citation
DOI: https://doi.org/10.1007/978-94-017-8896-0_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-8895-3
Online ISBN: 978-94-017-8896-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)